NCT01156779View on ClinicalTrials.gov

Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

April 30, 2012

Conditions
Diabetes Mellitus
Interventions
DRUG

SR-exenatide

Emulsion 0.5mg,1mg,2mg,4mg dosage (Dose-escalation) Single injection

Trial Locations (1)

Unknown

Clinical Trial center, Clinical Research institute, Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY